
Bethany P. Barham
Examiner (ID: 4188)
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615, 1611 |
| Total Applications | 647 |
| Issued Applications | 299 |
| Pending Applications | 38 |
| Abandoned Applications | 318 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18056449
[patent_doc_number] => 20220387535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MORINGA PLANT COMPONENTS
[patent_app_type] => utility
[patent_app_number] => 17/825438
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17825438
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/825438 | COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MORINGA PLANT COMPONENTS | May 25, 2022 | Pending |
Array
(
[id] => 19723999
[patent_doc_number] => 20250026750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => SULFOXIMINE-CONTAINING ATR INHIBITOR COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/569592
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569592
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/569592 | SULFOXIMINE-CONTAINING ATR INHIBITOR COMPOUND | May 11, 2022 | Pending |
Array
(
[id] => 19279841
[patent_doc_number] => 20240216313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => ELAFIBRANOR DERIVATIVES AGONISTS OF PPAR FOR USE IN THE TREATMENT OF SEPSIS
[patent_app_type] => utility
[patent_app_number] => 18/289213
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289213
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289213 | ELAFIBRANOR DERIVATIVES AGONISTS OF PPAR FOR USE IN THE TREATMENT OF SEPSIS | May 9, 2022 | Pending |
Array
(
[id] => 17790453
[patent_doc_number] => 20220249544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/728601
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728601 | COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF | Apr 24, 2022 | Pending |
Array
(
[id] => 17958532
[patent_doc_number] => 20220339112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => TARGETED CHEMICAL DELIVERY CAPSULE
[patent_app_type] => utility
[patent_app_number] => 17/711948
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711948
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/711948 | TARGETED CHEMICAL DELIVERY CAPSULE | Mar 31, 2022 | Pending |
Array
(
[id] => 20663609
[patent_doc_number] => 12605358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-21
[patent_title] => Composition for preventing or treating nervous system diseases comprising compound that inhibits mTOR signaling pathway as active ingredient
[patent_app_type] => utility
[patent_app_number] => 18/277701
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 21
[patent_no_of_words] => 12022
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277701
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277701 | Composition for preventing or treating nervous system diseases comprising compound that inhibits mTOR signaling pathway as active ingredient | Feb 15, 2022 | Issued |
Array
(
[id] => 17576862
[patent_doc_number] => 20220133717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => RABEXIMOD IN THE TREATMENT OF RHEUMATOID ARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 17/559057
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17559057
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/559057 | RABEXIMOD IN THE TREATMENT OF RHEUMATOID ARTHRITIS | Dec 21, 2021 | Abandoned |
Array
(
[id] => 18829646
[patent_doc_number] => 20230398170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => A THERAPEUTIC OIL COMPOSITION AND A PROCESS FOR ITS PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/030372
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030372
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030372 | A THERAPEUTIC OIL COMPOSITION AND A PROCESS FOR ITS PREPARATION | Dec 6, 2021 | Abandoned |
Array
(
[id] => 17480672
[patent_doc_number] => 20220088176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => ADJUVANTED NANOPARTICULATE INFLUENZA VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/543353
[patent_app_country] => US
[patent_app_date] => 2021-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17543353
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/543353 | ADJUVANTED NANOPARTICULATE INFLUENZA VACCINE | Dec 5, 2021 | Abandoned |
Array
(
[id] => 18817406
[patent_doc_number] => 20230391746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => SOLID STATE FORMS OF PRALSETINIB AND PROCESS FOR PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/032208
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032208
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032208 | SOLID STATE FORMS OF PRALSETINIB AND PROCESS FOR PREPARATION THEREOF | Oct 18, 2021 | Pending |
Array
(
[id] => 18724185
[patent_doc_number] => 20230338307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => PROPHYLACTIC AGENT, AMELIORATING AGENT, AND THERAPEUTIC AGENT FOR DRY EYE
[patent_app_type] => utility
[patent_app_number] => 18/246508
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246508
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246508 | PROPHYLACTIC AGENT, AMELIORATING AGENT, AND THERAPEUTIC AGENT FOR DRY EYE | Sep 23, 2021 | Pending |
Array
(
[id] => 20622566
[patent_doc_number] => 12590063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => Phenol derivative
[patent_app_type] => utility
[patent_app_number] => 18/043864
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23586
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043864
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043864 | Phenol derivative | Sep 2, 2021 | Issued |
Array
(
[id] => 18647739
[patent_doc_number] => 20230293509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => METHOD AND COMPOUND FOR USE, IN TREATING AND/OR PREVENTING NETOSIS
[patent_app_type] => utility
[patent_app_number] => 18/041393
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041393
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041393 | METHOD AND COMPOUND FOR USE, IN TREATING AND/OR PREVENTING NETOSIS | Aug 11, 2021 | Abandoned |
Array
(
[id] => 18901387
[patent_doc_number] => 20240016872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => COMPOSITION FOR PREVENTING OR AMELIORATING BROMHIDROSIS COMPRISING SEED FERMENTATION PRODUCT OF PLANT BELONGING TO THE GENUS LOTUS
[patent_app_type] => utility
[patent_app_number] => 18/108754
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18108754
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/108754 | COMPOSITION FOR PREVENTING OR AMELIORATING BROMHIDROSIS COMPRISING SEED FERMENTATION PRODUCT OF PLANT BELONGING TO THE GENUS LOTUS | Jun 28, 2021 | Pending |
Array
(
[id] => 18483485
[patent_doc_number] => 20230210782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => NON-PORCINE FORMULATIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/009619
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009619
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009619 | NON-PORCINE FORMULATIONS AND METHODS THEREOF | Jun 16, 2021 | Abandoned |
Array
(
[id] => 17412600
[patent_doc_number] => 20220047504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => ORAL DISSOLVABLE FILM WITH PORES EXTENDING THERETHROUGH
[patent_app_type] => utility
[patent_app_number] => 17/331731
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17331731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/331731 | ORAL DISSOLVABLE FILM WITH PORES EXTENDING THERETHROUGH | May 26, 2021 | Abandoned |
Array
(
[id] => 18581648
[patent_doc_number] => 20230263901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => MUCUS ADHESION DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/040315
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040315
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040315 | MUCUS ADHESION DRUG DELIVERY | Jan 28, 2021 | Abandoned |
Array
(
[id] => 16086799
[patent_doc_number] => 20200197386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => Aza-Aryl 1H-Pyrazol-yl Benzene Sulfonamides
[patent_app_type] => utility
[patent_app_number] => 16/807891
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807891
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/807891 | Aza-Aryl 1H-Pyrazol-yl Benzene Sulfonamides | Mar 2, 2020 | Abandoned |
Array
(
[id] => 17183700
[patent_doc_number] => 20210330585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => METHOD FOR REDUCING PARASITE BURDEN IN A MOSQUITO
[patent_app_type] => utility
[patent_app_number] => 17/271384
[patent_app_country] => US
[patent_app_date] => 2019-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271384
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/271384 | Method for reducing parasite burden in a mosquito | Sep 2, 2019 | Issued |
Array
(
[id] => 16627336
[patent_doc_number] => 20210045989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => EYELINER PRODUCT AND METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/548866
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16548866
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/548866 | EYELINER PRODUCT AND METHOD THEREOF | Aug 22, 2019 | Abandoned |